Collaborative helped a research company transitioning to commercialization identify critical timelines, tasks, milestones and resources required to bring a new drug to market. As part of the project, leaders were given the information and tools they needed and the business began building the strong foundation necessary for a successful launch.
Commercial launch is a critical and complex period in the Life Sciences product life cycle. The transition from clinical development to commercial operations can seem overwhelming as companies face considerable challenges in transforming from an R&D-driven organization to one focused on achieving in-market business and commercial excellence. Core to successful launches is preparing the company for a whole new raft of capabilities, processes, and relationships, and in doing so there are a number of factors included in this checklist that companies should consider and questions they should answer.
IBM Watson Health aims to transform the drug development process for life sciences – from research to commercialization. IBM Watson for Drug Discovery helps accelerate breakthroughs by enabling researchers to quickly analyze, identify, and prioritize new therapeutic targets and drug combinations for future study.
BM Watson Health aims to transform the drug development process for life sciences – from research to commercialization. IBM Watson for Drug Discovery helps accelerate breakthroughs by enabling researchers to quickly analyze, identify, and prioritize new therapeutic targets and drug combinations for future study.
Integration technology is powerful, providing sophisticated features that enable organizations to create complex links and connections across diverse applications and systems. And that‘s why integration projects historically required deep expertise in integration technology, as well as command of integration architectures and patterns. If it sounds complex, that‘s because it was. Not just anyone could be an integration specialist.
But with cloud applications becoming mainstream, many people are facing a new kind of integration challenge. Departmental owners of cloud-based applications now have to learn a few lessons that their counterparts in IT have known for a long time. Applications operate as part of a larger IT landscape, not a vacuum. For applications to be useful, they need data. And at least some of that data already exists in other systems, whether in the cloud or on-premises.
As cloud apps have become more mainstream, so has the commercialization of applications and user in